Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.060 +0.107 (+11.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
73 Biggest Movers From Yesterday
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB 
Via Benzinga
OCGN Stock Alert: Why Is Ocugen Heating Up Today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug candidate. 
Via InvestorPlace
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to avoid OCGN stock. 
Via InvestorPlace
Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval
Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point. 
Via InvestorPlace
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led... 
Via Benzinga
Production Updates Could Give Novavax Stock a Big Boost
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,... 
Via Benzinga
Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points
U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would... 
Via Benzinga
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
Ocugen Inc (NASDAQ: OCGN) has  
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday... 
Via Benzinga
Dow Drops Triple Digits as Investors Eye Sanctions
The Dow Jones Industrial Average is down 292 points midday. The S&P 500 Index and Nasdaq Composite are sharply lower as well, as the major indexes begin their holiday-shortened week after their... 
Via Talk Markets
Dear AMC Stock Fans, Mark Your Calendars for March 1
Investors in AMC Entertainment (AMC) stock are going to want to keep an eye on the movie theater company when March 1 rolls around. 
Via InvestorPlace
Chinese Stocks Alert: Why Are BABA, TCEHY, JD, PDD Stocks Down Today?
Chinese tech stocks are taking a beating on Tuesday as investors worry about additional restrictions from the country's government. 
Via InvestorPlace
Why Ocugen Shares Are Rising
Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US
The FDA has lifted its clinical hold on Ocugen Inc's (NASDAQ: OCGN) investigational new drug application seeking approval to conduct testing of the COVID-... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apple’s App Store, Donald... 
Via Benzinga
Ocugen Stock Finally Sunk to Penny Status, But That Doesn’t Make It a Buy
An interview with Dr. Anthony Fauci about the Covaxin vaccine makes you wonder why investors have any interest in OCGN stock. 
Via InvestorPlace
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
OCGN stock is definitely out of favor on Wall Street, but fresh poll data and an imminent R&D hub acquisition should spur some optimism. 
Via InvestorPlace
Ocugen Stock Is a Fairy Tale in Need of a Happy Ending
If you’re investing in OCGN stock, you have to wonder: how much upside can FDA approval really give this beleaguered name? 
Via InvestorPlace
Novavax Stock Is at Risk Despite Positive Poll Results
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying. 
Via InvestorPlace
Who's Winning - The 'Shorters' Or The 'Squeezers'?
A look at how well the 'squeezers' are doing relative to the 
Via Talk Markets
Two Reasons to Skip Ocugen Stock Despite Some Good News
Ocugen was one of the most explosive stocks on the market, all thanks to its coronavirus vaccine, Covaxin. But don't rush to buy just yet. 
Via InvestorPlace
With No Vaccine Approval, Ocugen Is the Definition of Dead Money
Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue. 
Via InvestorPlace
3 Biotech Stocks That Could Boom or Bust in Q1
The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future. 
Via InvestorPlace
Despite Big Disappointment, There’s Still Potential With Ocugen Stock
As this biotech's stock continues to slide lower in price, risk-tolerant investors may find an opportunity with beaten down OCGN stock. 
Via InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation... 
Via Benzinga
Novavax Appears to be Running Out of Options
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point. 
Via InvestorPlace
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.